Daewon Pharmaceutical Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1958-01-07
- Employees
- 1.2K
- Market Cap
- -
- Website
- http://www.daewonpharm.com
Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-01-30
- Last Posted Date
- 2016-10-10
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 183
- Registration Number
- NCT01779271
- Locations
- 🇰🇷
Chung-Ang University Hospital, South Korea, Seoul, Korea, Republic of
Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-01-28
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Registration Number
- NCT01776515
Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-01-28
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Registration Number
- NCT01776697
Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2016-10-12
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT01606059
- Locations
- 🇰🇷
Chungnam National University Hospital, DaeJeon, Korea, Republic of
Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition
- First Posted Date
- 2012-05-02
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT01589562
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath